Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT05350202
Status:
COMPLETED
Last Update Posted:
2025-08-26
First Post:
2022-04-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Emp-Activity: Empagliflozin Functional Capacity
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-22
First Submit QC Date:
None
Study First Post Date:
2022-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-16
Results First Submit QC Date:
None
Results First Post Date:
2025-08-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-21
Last Update Post Date:
2025-08-26
Last Update Post Date Type:
ESTIMATED